Results 271 to 280 of about 1,610,408 (351)

Optimization of Helical Pitch in Cardiac MDCT Acquisition in Patients with Arrhythmia Requiring ECG-edit

open access: diamond, 2008
Hideyuki Matsutani   +6 more
openalex   +2 more sources

Advancing cardio‐obstetric care through digital health technologies: A narrative review

open access: yesESC Heart Failure, EarlyView.
Telehealth has enhanced prenatal and post‐partum care by improving access, continuity, and equity, particularly for high‐risk and underserved populations, without compromising maternal or fetal outcomes. Wearable and digital health technologies (e.g., electrocardiogram sensors, remote BP monitoring, mobile interventions) show strong potential to ...
Toluwalase Awoyemi   +11 more
wiley   +1 more source

Prediction of Cardiac Arrhythmias in Cancer Patients Treated with Immune Checkpoint Inhibitors Using Electrocardiogram. [PDF]

open access: yesDiagnostics (Basel)
Coskun A   +12 more
europepmc   +1 more source

Abnormal Ca<sup>2+</sup> handling and reduced I<sub>to</sub> contribute to citalopram-induced QT prolongation and cardiac arrhythmias. [PDF]

open access: yesFront Pharmacol
Li Y   +11 more
europepmc   +1 more source

Worsening versus advanced heart failure: Management and challenges

open access: yesESC Heart Failure, EarlyView.
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli   +15 more
wiley   +1 more source

Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias. [PDF]

open access: yesJ Cardiovasc Dev Dis
Yavin H   +4 more
europepmc   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

open access: yesESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy